BAKER BROS. ADVISORS LP Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$12.2B
Holdings
119
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (119 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —Immune Design Corp. | 148,937 | $1.0B | 8.29% | |
| 102 | —Affimed N.V. | 400,000 | $920.0M | 7.53% | |
| 103 | MDGLMadrigal Pharmaceuticals, Inc. | 57,762 | $890.0M | 7.28% | |
| 104 | XLRNAcceleron Pharma Inc. | 28,765 | $761.0M | 6.23% | |
| 105 | CMRXEURChimerix, Inc. | 115,216 | $735.0M | 6.01% | |
| 106 | —Five Prime Therapeutics, Inc. | 19,247 | $696.0M | 5.70% | |
| 107 | —Palatin Technologies, Inc. | 2,050,000 | $671.0M | 5.49% | |
| 108 | I9DNArbutus Biopharma Corporation | 180,582 | $587.0M | 4.80% | |
| 109 | —Ritter Pharmaceuticals, Inc. | 400,000 | $568.0M | 4.65% | |
| 110 | ADAPYAdaptimmune Therapeutics plc | 100,000 | $551.0M | 4.51% | |
| 111 | —Proteon Therapeutics, Inc. | 298,591 | $523.0M | 4.28% | |
| 112 | —Bioverativ Inc. | 8,249 | $449.0M | 3.67% | |
| 113 | DVAXDynavax Technologies Corporation | 75,000 | $446.0M | 3.65% | |
| 114 | —BioDelivery Sciences International, Inc. | 210,021 | $399.0M | 3.26% | |
| 115 | CCXIEURChemoCentryx, Inc. | 49,064 | $357.0M | 2.92% | |
| 116 | —Windtree Therapeutics, Inc. | 254,973 | $291.0M | 2.38% | |
| 117 | —BioPharmX Corporation | 377,295 | $191.0M | 1.56% | |
| 118 | BGMS 6 PERPCyclacel Pharmaceuticals, Inc. | 13,253 | $83.0M | 0.68% | |
| 119 | —BioTime, Inc. | 20,084 | $12.0M | 0.10% |
PreviousPage 2 of 2